CELON PHARMA S A

🇵🇱Poland

Country: 🇵🇱Poland

Ownership: Public

Established: 2002-01-01

Employees: 515

Market Cap: $412.8M

Website: http://www.celonpharma.com

Clinical Trials

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Esketamine DPI
Drug: Placebo DPI

First Posted Date: 2018-01-23

Last Posted Date: 2018-07-12

Lead Sponsor: Celon Pharma SA

Target Recruit Count: 63

Registration Number: NCT03407872

Locations: 🇵🇱
BioResearch Group Sp. z o.o., Kajetany, Poland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy